Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ: CPIX · Real-Time Price · USD
2.940
+0.030 (1.03%)
Aug 13, 2025, 4:00 PM - Market closed
CPIX Revenue
Cumberland Pharmaceuticals had revenue of $10.84M in the quarter ending June 30, 2025, with 10.04% growth. This brings the company's revenue in the last twelve months to $42.07M, up 11.34% year-over-year. In the year 2024, Cumberland Pharmaceuticals had annual revenue of $37.87M, down -4.26%.
Revenue (ttm)
$42.07M
Revenue Growth
+11.34%
P/S Ratio
1.01
Revenue / Employee
$462,328
Employees
91
Market Cap
43.83M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 37.87M | -1.68M | -4.26% |
Dec 31, 2023 | 39.55M | -2.46M | -5.85% |
Dec 31, 2022 | 42.01M | 6.03M | 16.75% |
Dec 31, 2021 | 35.99M | -1.46M | -3.89% |
Dec 31, 2020 | 37.44M | 3.05M | 8.88% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
CPIX News
- 8 days ago - Cumberland Pharmaceuticals Inc. (CPIX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Cumberland Pharmaceuticals Reports 23% Revenue Growth Year-to-Date - PRNewsWire
- 10 days ago - CUMBERLAND PHARMACEUTICALS RECEIVES VIZIENT CONTRACT FOR NEW VIBATIV® 4-VIAL STARTER PAK - PRNewsWire
- 15 days ago - CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q2 2025 FINANCIAL RESULTS & COMPANY UPDATE - PRNewsWire
- 7 weeks ago - Cumberland Pharmaceuticals Shares Phase 2 FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference - PRNewsWire
- 2 months ago - NEW STUDY FINDS CALDOLOR® SAFE AND EFFECTIVE FOR OPIOID-SPARING PAIN MANAGEMENT IN OLDER ADULTS - PRNewsWire
- 3 months ago - CUMBERLAND PHARMACEUTICALS PARTNERS WITH QUREIGHT TO ADVANCE INNOVATIVE IDIOPATHIC PULMONARY FIBROSIS TREATMENT RESEARCH - PRNewsWire
- 3 months ago - Cumberland Pharmaceuticals, Inc. (CPIX) Q1 2025 Earnings Call Transcript - Seeking Alpha